1. IDDF2020-ABS-0166 Novel mirna-based drug CD5–2 reduces liver tumour growth in diethylnitrosamine (DEN)-treated mice by normalising tumour vasculature and altering immune infiltrate. (18th November 2020) Authors: Liu, Ken; Zhao, Yang; Chen, Jinbiao; Boland, Jade; Ting, Ka Ka; Gamble, Jennifer; McCaughan, Geoffrey Journal: Gut Issue: Volume 69(2020)Supplement 2 Page Start: A2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗